Literature DB >> 19530184

Review of disrupted sleep patterns in Smith-Magenis syndrome and normal melatonin secretion in a patient with an atypical interstitial 17p11.2 deletion.

Eilis A Boudreau1, Kyle P Johnson, Angela R Jackman, Jan Blancato, Marjan Huizing, Claude Bendavid, Marypat Jones, Settara C Chandrasekharappa, Alfred J Lewy, Ann C M Smith, R Ellen Magenis.   

Abstract

Smith-Magenis syndrome (SMS) is a disorder characterized by multiple congenital anomalies and behavior problems, including abnormal sleep patterns. It is most commonly due to a 3.5 Mb interstitial deletion of chromosome 17 band p11.2. Secretion of melatonin, a hormone produced by the pineal gland, is the body's signal for nighttime darkness. Published reports of 24-hr melatonin secretion patterns in two independent SMS cohorts (US and France) document an inverted endogenous melatonin pattern in virtually all cases (96%), suggesting that this finding is pathognomic for the syndrome. We report on a woman with SMS due to an atypical large proximal deletion ( approximately 6Mb; cen<->TNFRSFproteinB) of chromosome band (17)(p11.2p11.2) who presents with typical sleep disturbances but a normal pattern of melatonin secretion. We further describe a melatonin light suppression test in this patient. This is the second reported patient with a normal endogenous melatonin rhythm in SMS associated with an atypical large deletion. These two patients are significant because they suggest that the sleep disturbances in SMS cannot be solely attributed to the abnormal diurnal melatonin secretion versus the normal nocturnal pattern.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19530184      PMCID: PMC2760428          DOI: 10.1002/ajmg.a.32846

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  34 in total

1.  Hemizygosity for the COP9 signalosome subunit gene, SGN3, in the Smith-Magenis syndrome.

Authors:  S H Elsea; K Mykytyn; K Ferrell; K L Coulter; P Das; W Dubiel; P I Patel; J E Metherall
Journal:  Am J Med Genet       Date:  1999-12-03

Review 2.  Sleep disturbances in the wake of traumatic events.

Authors:  P Lavie
Journal:  N Engl J Med       Date:  2001-12-20       Impact factor: 91.245

3.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

4.  Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome.

Authors:  H De Leersnyder; M C De Blois; B Claustrat; S Romana; U Albrecht; J C Von Kleist-Retzow; B Delobel; G Viot; S Lyonnet; M Vekemans; A Munnich
Journal:  J Pediatr       Date:  2001-07       Impact factor: 4.406

5.  Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome.

Authors:  L Potocki; D Glaze; D X Tan; S S Park; C D Kashork; L G Shaffer; R J Reiter; J R Lupski
Journal:  J Med Genet       Date:  2000-06       Impact factor: 6.318

6.  RAI1 point mutations, CAG repeat variation, and SNP analysis in non-deletion Smith-Magenis syndrome.

Authors:  Weimin Bi; G Mustafa Saifi; Santhosh Girirajan; Xin Shi; Barbara Szomju; Helen Firth; R Ellen Magenis; Lorraine Potocki; Sarah H Elsea; James R Lupski
Journal:  Am J Med Genet A       Date:  2006-11-15       Impact factor: 2.802

7.  beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome.

Authors:  H De Leersnyder; M C de Blois; M Vekemans; D Sidi; E Villain; C Kindermans; A Munnich
Journal:  J Med Genet       Date:  2001-09       Impact factor: 6.318

Review 8.  New developments in Smith-Magenis syndrome (del 17p11.2).

Authors:  Andrea L Gropman; Sarah Elsea; Wallace C Duncan; Ann C M Smith
Journal:  Curr Opin Neurol       Date:  2007-04       Impact factor: 5.710

9.  Mutations in RAI1 associated with Smith-Magenis syndrome.

Authors:  Rebecca E Slager; Tiffany Lynn Newton; Christopher N Vlangos; Brenda Finucane; Sarah H Elsea
Journal:  Nat Genet       Date:  2003-03-24       Impact factor: 38.330

10.  Patient with large 17p11.2 deletion presenting with Smith-Magenis syndrome and Joubert syndrome phenotype.

Authors:  F Natacci; L Corrado; M Pierri; M Rossetti; C Zuccarini; P Riva; M Miozzo; L Larizza
Journal:  Am J Med Genet       Date:  2000-12-18
View more
  14 in total

Review 1.  Yin-yang actions of histone methylation regulatory complexes in the brain.

Authors:  Patricia Marie Garay; Margarete Aryanka Wallner; Shigeki Iwase
Journal:  Epigenomics       Date:  2016-11-18       Impact factor: 4.778

2.  Twenty-four-hour motor activity and body temperature patterns suggest altered central circadian timekeeping in Smith-Magenis syndrome, a neurodevelopmental disorder.

Authors:  Ann C M Smith; Rebecca S Morse; Wendy Introne; Wallace C Duncan
Journal:  Am J Med Genet A       Date:  2019-02       Impact factor: 2.802

3.  Treatment of dyssomnias and parasomnias in childhood.

Authors:  Suresh Kotagal
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

4.  Auditory Phenotype of Smith-Magenis Syndrome.

Authors:  Megan A Brendal; Kelly A King; Christopher K Zalewski; Brenda M Finucane; Wendy Introne; Carmen C Brewer; Ann C M Smith
Journal:  J Speech Lang Hear Res       Date:  2017-04-14       Impact factor: 2.297

Review 5.  Rhythms of life: circadian disruption and brain disorders across the lifespan.

Authors:  Ryan W Logan; Colleen A McClung
Journal:  Nat Rev Neurosci       Date:  2019-01       Impact factor: 34.870

Review 6.  Melatonin and the skeleton.

Authors:  A K Amstrup; T Sikjaer; L Mosekilde; L Rejnmark
Journal:  Osteoporos Int       Date:  2013-05-29       Impact factor: 4.507

7.  Circadian abnormalities in mouse models of Smith-Magenis syndrome: evidence for involvement of RAI1.

Authors:  Melanie Lacaria; Wenli Gu; James R Lupski
Journal:  Am J Med Genet A       Date:  2013-05-23       Impact factor: 2.802

8.  Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity.

Authors:  Stephen R Williams; Deborah Zies; Sureni V Mullegama; Michael S Grotewiel; Sarah H Elsea
Journal:  Am J Hum Genet       Date:  2012-05-10       Impact factor: 11.025

9.  Diagnostic utility of daytime salivary melatonin levels in Smith-Magenis syndrome.

Authors:  Constance L Chik; Mark D Rollag; Wallace C Duncan; Ann C M Smith
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

Review 10.  Congenital scoliosis in Smith-Magenis syndrome: a case report and review of the literature.

Authors:  Zheng Li; Jianxiong Shen; Jinqian Liang; Lin Sheng
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.